https://www.selleckchem.com/ALK.html
0001). IABP use was associated with lower crude in-hospital mortality in each SCAI shock stage (all p .05, except p=.08 in SCAI shock stage E). We did not observe any significant heterogeneity in the association between IABP use and in-hospital mortality as a function of SCAI shock stage. IABP use was associated with substantially lower in-hospital mortality in patients with CS, without differences in this effect across the SCAI shock stages. Future studies should account for the severity and etiology of shock when evaluating the efficacy of IA
Like
Comment
Share
